Drugs that contain Selumetinib Sulfate
1. Drug name - KOSELUGO
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US8178693 | ASTRAZENECA | N3 alkylated benzimidazole derivatives as MEK inhibitors |
Mar, 2023
(5 months from now) | |
| US7425637 | ASTRAZENECA | N3 alkylated benzimidazole derivatives as MEK inhibitors |
Apr, 2024
(1 year, 6 months from now) | |
| US9562017 | ASTRAZENECA | Hydrogen sulfate salt |
Dec, 2026
(4 years from now) | |
| US9156795 | ASTRAZENECA | Hydrogen sulfate salt |
Dec, 2026
(4 years from now) | |
| CN1874768A | ASTRAZENECA | N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors |
Jan, 2010
(12 years ago) | |
| CN102329270A | ASTRAZENECA | Hydrosulfate |
Dec, 2014
(7 years ago) | |
| CN101633644A | ASTRAZENECA | N3 Alkylated Benzimidazole Derivative Used As Mek Inhibitor |
Mar, 2023
(5 months from now) | |
| CN101633645B | ASTRAZENECA | N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors |
Mar, 2023
(5 months from now) | |
| CN101633644B | ASTRAZENECA | N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors |
Mar, 2023
(5 months from now) | |
| CN100519539C | ASTRAZENECA | N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors |
Mar, 2023
(5 months from now) | |
| CN1652776A | ASTRAZENECA | N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors |
Mar, 2023
(5 months from now) | |
| CN101486682A | ASTRAZENECA | N3 Alkylated Benzoimidazole Derivatives As Mek Inhibitors |
Mar, 2023
(5 months from now) | |
| CN101486682B | ASTRAZENECA | N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors |
Mar, 2023
(5 months from now) | |
| CN101633645A | ASTRAZENECA | N3 Alkylated Benzimidazole Derivative Used As Mek Inhibitor |
Mar, 2023
(5 months from now) | |
| CN101360718A | ASTRAZENECA | Novel Hydrogen Sulphate Salt |
Dec, 2026
(4 years from now) | |
| CN101360718B | ASTRAZENECA | Hydrosulfate |
Dec, 2026
(4 years from now) | |
| IN200403046P1 | ASTRAZENECA | N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors |
Mar, 2023
(5 months from now) | |
| IN248684B | ASTRAZENECA | N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors |
Mar, 2023
(5 months from now) | |
| EP2130536A1 | ASTRAZENECA | N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors |
Mar, 2023
(5 months from now) | |
| EP2130537A1 | ASTRAZENECA | N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors |
Mar, 2023
(5 months from now) | |
| EP2130537B1 | ASTRAZENECA | N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors |
Mar, 2023
(5 months from now) | |
| EP2275102B1 | ASTRAZENECA | N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors |
Mar, 2023
(5 months from now) | |
| EP3000810A1 | ASTRAZENECA | N3 Alkylated Benzimidazole Derivative As Mek Inhibitor |
Mar, 2023
(5 months from now) | |
| EP2275102A1 | ASTRAZENECA | N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors |
Mar, 2023
(5 months from now) | |
| EP2130536B1 | ASTRAZENECA | N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors |
Mar, 2023
(5 months from now) | |
| EP3000810B1 | ASTRAZENECA | N3 Alkylated Benzimidazole Derivative As Mek Inhibitor |
Mar, 2023
(5 months from now) | |
| EP1482932A1 | ASTRAZENECA | N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors |
Mar, 2023
(5 months from now) | |
| EP1482932B1 | ASTRAZENECA | N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors |
Mar, 2023
(5 months from now) | |
| EP1482932A4 | ASTRAZENECA | N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors |
Mar, 2023
(5 months from now) | |
| EP1663210A4 | ASTRAZENECA | N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors |
Aug, 2024
(1 year, 10 months from now) | |
| EP1663210A1 | ASTRAZENECA | Benzimidazole Derivatives As Mek Inhibitors |
Aug, 2024
(1 year, 10 months from now) | |
| EP1663210B1 | ASTRAZENECA | Benzimidazole Derivatives As Mek Inhibitors |
Aug, 2024
(1 year, 10 months from now) | |
| EP1968948A2 | ASTRAZENECA | Novel Hydrogen Sulfate Salt |
Dec, 2026
(4 years from now) | |
| EP1968948B1 | ASTRAZENECA | Novel Hydrogen Sulfate Salt |
Dec, 2026
(4 years from now) | |
| EP1968948A4 | ASTRAZENECA | Novel Hydrogen Sulfate Salt |
Dec, 2026
(4 years from now) | |
Treatment: NA
Dosage: CAPSULE;ORAL
| Strength | Dosage | Availability |
|---|---|---|
| EQ 10MG BASE | CAPSULE;ORAL | Prescription |
| EQ 25MG BASE | CAPSULE;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.